Correlation of estradiol, parathyroid hormone, interleukin-6, and soluble interleukin-6 receptor during the normal menstrual cycle

Bone

Volumn 26, Issue 1, 2000, Pages 79-85

  Chiu, K M ^a,b   Arnaud, C D ^b   Ju, J ^d   Mayes, D ^e   Bacchetti, P ^c   Weitz, S ^d   Keller, E T ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Quidel Corporation   (United States)

^e Endocrine Sciences   (United States)

Author keywords

Deoxypyridinoline (Dpd); Estradiol (E2); Interleukin 6 (IL 6); Menstrual cycle; Parathyroid hormone (PTH)

Indexed keywords

ALKALINE PHOSPHATASE; CYTOKINE; DEOXYPYRIDINOLINE; ESTRADIOL; FOLLITROPIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LUTEINIZING HORMONE; OSTEOCALCIN; PARATHYROID HORMONE; PROGESTERONE; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BONE ATROPHY; BONE METABOLISM; BONE MINERAL; BONE REMODELING; CALCIUM METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; NORMAL HUMAN; OSTEOLYSIS;

ADULT; BIOLOGICAL MARKERS; BONE REMODELING; CALCIUM; ESTRADIOL; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MENSTRUAL CYCLE; PARATHYROID HORMONE; RECEPTORS, INTERLEUKIN-6; SOLUBILITY;

EID: 0033990926     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(99)00243-4     Document Type: Article

References (68)

1. Abdalla H.I., Hart D.M., Lindsay R., Leggate I., Hooke A. Prevention of bone mineral loss in postmenopausal women by norethisterone. Obstet Gynecol. 66:1985;789-792.
2. Angstwurm M.W., Gartner R., Ziegler-Heitbrock H.W. Cyclic plasma IL-6 levels during normal menstrual cycle. Cytokine. 9:1997;370-374.
3. Bismar H., Diel I., Ziegler R., Pfeilschifter J. Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab. 80:1995;3351-3355.
4. Bodine P.V., Green J., Harris H.A., Bhat R.A., Stein G.S., Lian J.B., Komm B.S. Functional properties of a conditionally phenotypic, estrogen-responsive, human osteoblast cell line. J Cell Biochem. 65:1997;368-387.
5. Bodine P.V., Harris H.A., Komm B.S. Suppression of ligand-dependent estrogen receptor activity by bone-resorbing cytokines in human osteoblasts. Endocrinology. 140:1999;2439-2451.
6. Bornefalk E., Ljunghall S., Lindh E., Bengtson O., Johansson A.G., Ljunggren O. Regulation of interleukin-6 secretion from mononuclear blood cells by extracellular calcium. J Bone Miner Res. 12:1997;228-233.
7. Cantatore F.P., Loverro G., Ingrosso A.M., Lacanna R., Sassanelli E., Selvaggi L., Carrozzo M. Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause. Clin Rheumatol. 14:1995;157-160.
8. Chaudhary L.R., Spelsberg T.C., Riggs B.L. Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1β and tumor necrosis factor-α Lack of regulation by 17β-estradiol . Endocrinology. 130:1992;2528-2534.
9. Cheleuitte D., Mizuno S., Glowacki J. In vitro secretion of cytokines by human bone marrow Effects of age and estrogen status . J Clin Endocrinol Metab. 83:1998;2043-2051.
10. Cummings S.R., Block G., McHenry K., Baron R.B. Evaluation of two food frequency methods of measuring dietary calcium intake. Am J Epidemiol. 126:1987;796-802.
11. De Benedetti F., Massa M., Pignatti P., Albani S., Novick D., Martini A. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest. 93:1994;2114-2119.
12. de Grooth R., Kawilarang-de Haas E.W., van de Sande-Rijkers C.M., Nijweide P.J. The role of osteoblast density and endogenous interleukin-6 production in osteoclast formation from the hemopoietic stem cell line FDCP-MIX C2GM in coculture with primary osteoblasts. Calcif Tissue Int. 63:1998;57-62.
13. Dequeker J., De Muylder E. Long-term progestogen treatment and bone remodelling in peri-menopausal women A longitudinal study . Maturitas. 4:1982;309-313.
14. Diggle P., Liang K.-Y., Zeger S. Analysis of Longitudinal Data. 1994;Oxford University Press, Oxford, UK.
15. Epstein E., Silver J., Almogi G., Livni N., Naveh-Many T. Parathyroid hormone mRNA levels are increased by progestins and vary during rat estrous cycle. Am J Physiol. 270:1996;E158-E163.
16. Feyen H.J.M., Elford P., Ki Padova F.E., Trechsel U. Interleukin-6 is produced by bone and modulated by parathyroid hormone. J Bone Miner Res. 4:1989;633-638.
17. Gorai I., Taguchi Y., Chaki O., Kikuchi R., Nakayama M., Yang B., Yokota S., Minaguchi H. Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle. J Clin Endocrinol Metab. 83:1998;326-332.
18. Greenfield E.M., Gornik S.A., Horowitz M.C., Donahue H.J., Shaw S.M. Regulation of cytokine expression in osteoblasts by parathyroid hormone Rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA . J Bone Miner Res. 8:1993;1163-1171.
19. Harms H.M., Neubauer O., Kayser C., Wustermann P.R., Horn R., Brosa U., Schlinke E., Kulpmann W.R., von zur Muhlen A., Hesch R.D. Pulse amplitude and frequency modulation of parathyroid hormone in early postmenopausal women before and on hormone replacement therapy. J Clin Endocrinol Metab. 78:1994;48-52.
20. Hofbauer L.C., Khosla S., Dunstan C.R., Lacey D.L., Spelsberg T.C., Riggs B.L. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology. 140:1999;4367-4370.
21. Hughes D.E., Dai A., Tiffee J.C., Li H.H., Mundy G.R., Boyce B.F. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nature Med. 2:1996;1132-1136.
22. Jilka R.L., Hangoc G., Girasole G., Passeri G., Williams D.C., Abrams J.S., Boyce B., Broxmeyer H., Manolagas S.C. Increased osteoclast development after estrogen loss Mediation by interleukin-6 . Science. 257:1992;88-91.
23. Jilma B., Dirnberger E., Loscher I., Rumplmayr A., Hildebrandt J., Eichler H.G., Kapiotis S., Wagner O.F. Menstrual cycle-associated changes in blood levels of interleukin-6, alpha1 acid glycoprotein, and C-reactive protein. J Lab Clin Med. 130:1997;69-75.
24. Kassem M., Harris S.A., Spelsberg T.C., Riggs B.L. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. J Bone Miner Res. 11:1996;193-199.
25. Kassem M., Khosla S., Spelsberg T.C., Riggs B.L. Cytokine production in the bone marrow microenvironment Failure to demonstrate estrogen regulation in early postmenopausal women . J Clin Endocrinol Metab. 81:1996;513-518.
26. Kawaguchi H., Pilbeam C.C., Harrison J.R., Raisz L.G. The role of prostaglandins in the regulation of bone metabolism. Clin Orthop. 313:1995;36-46.
27. 2-restored bone in aged, ovariectomized rats. Bone. 24:1999;41-47.
28. Khosla S., Atkinson E.J., Melton L.J. III, Riggs B.L. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women A population-based study . J Clin Endocrinol Metab. 82:1997;1522-1527.
29. Khosla S., Peterson J.M., Egan K., Jones J.D., Riggs B.L. Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab. 79:1994;707-711.
30. Kimble R.B. Alcohol, cytokines, and estrogen in the control of bone remodeling. Alcohol Clin Exp Res. 21:1997;385-391.
31. Kimble R.B., Bain S., Pacifici R. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res. 12:1997;935-941.
32. Kimble R.B., Kitazawa R., Vannice J.L., Pacifici R. Persistent bone-sparing effect of interleukin-1 receptor antagonist A hypothesis on the role of IL-1 in ovariectomy-induced bone loss . Calcif Tissue Int. 55:1994;260-265.
33. Kitazawa R., Kimble R.B., Vannice J.L., Kung V.T., Pacifici R. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest. 94:1994;2397-2406.
34. Koka S., Petro T.M., Reinhardt R.A. Estrogen inhibits interleukin-1beta-induced interleukin-6 production by human osteoblast-like cells. J Interferon Cytokine Res. 18:1998;479-483.
35. Kurebayashi S., Miyashita Y., Hirose T., Kasayama S., Akira S., Kishimoto T. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor. J Ster Biochem Molec Biol. 60:1997;11-17.
36. Lea C.K., Sarma U., Flanagan A.M. Macrophage colony stimulating-factor transcripts are differentially regulated in rat bone-marrow by gender hormones. Endocrinology. 140:1999;273-279.
37. Ledger G.A., Burritt M.F., Kao P.C., O'Fallon W.M., Riggs B.L., Khosla S. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J Clin Endocrinol Metab. 80:1995;3304-3310.
38. Lin S.C., Yamate T., Taguchi Y., Borba V.Z., Girasole G., O'Brien C.A., Bellido T., Abe E., Manolagas S.C. Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J Clin Invest. 100:1997;1980-1990.
39. Lindsay R., Aitken J.M., Hart D.M., Purdie D. The effect of ovarian sex steroids on bone mineral status in the oophorectomized rat and in the human. Postgrad Med J. 54:1978;50-58.
40. Loret de Mola J.R., Baumgardner G.P., Goldfarb J.M., Friedlander M.A. Ovarian hyperstimulation syndrome Pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-alpha cannot predict its occurrence . Hum Reprod. 11:1996;1377-1380.
41. Makinoda S., Mikuni M., Sogame M., Kobamatsu Y., Furuta I., Yamada H., Yamamoto R., Fujimoto S. Erythropoietin, granulocyte-colony stimulating factor, interleukin-1 beta and interleukin-6 during the normal menstrual cycle. Int J Gynaecol Obstet. 55:1996;265-271.
42. Mandel F.P., Davidson B.J., Erlik Y., Judd H.L., Meldrum D.R. Effects of progestins on bone metabolism in postmenopausal women. J Reprod Med. 27:1982;511-514.
43. Manolagas S.C. The role of IL-6 type cytokines and their receptors in bone. Ann NY Acad Sci. 840:1998;194-204.
44. Marie P.J., Hott M., Launay J.M., Graulet A.M., Gueris J. In vitro production of cytokines by bone surface-derived osteoblastic cells in normal and osteoporotic postmenopausal women Relationship with cell proliferation . J Clin Endocrinol Metab. 77:1993;824-830.
45. Marriott I., Bost K.L., Mason M.J. Differential kinetics for induction of interleukin-6 mRNA expression in murine peritoneal macrophages Evidence for calcium-dependent and independent-signalling pathways . J Cell Physiol. 177:1998;232-240.
46. McKane W.R., Khosla S., Peterson J.M., Egan K., Riggs B.L. Circulating levels of cytokines that modulate bone resorption Effects of age and menopause in women . J Bone Miner Res. 9:1994;1313-1318.
47. McKane W.R., Khosla S., Risteli J., Robins S.P., Muhs J.M., Riggs B.L. Role of estrogen deficiency in pathogenesis of secondary hyperparathyroidism and increased bone resorption in elderly women. Proc Assoc Am Phys. 109:1997;174-180.
48. Onyia J.E., Libermann T.A., Bidwell J., Arnold D., Tu Y., McClelland P., Hock J.M. Parathyroid hormone (1-34)-mediated interleukin-6 induction. J Cell Biochem. 67:1997;265-274.
49. Pacifici R., Rifas L., McCracken R., Avioli L.V. The role of interleukin-1 in postmenopausal bone loss. Exp Gerontol. 25:1990;309-316.
50. Paterson M.E. A randomized double-blind cross-over trial into the effect of norethisterone on climacteric symptoms and biochemical profiles. Br J Obstet Gynaecol. 89:1982;464-472.
51. Pioli G., Basini G., Pedtazzoni M., Musetti G., Ulietti V., Bresciani D., Villa P., Bacchi A., Hughes D., Russel M., Passeri M. Spontaneous release of interleukin-1 and interleukin-6 by peripheral blood mononuclear cells after oophorectomy. Clin Sci. 83:1992;503-507.
52. Pollock J.H., Blaha M.J., Lavish S.A., Stevenson S., Greenfield E.M. In vivo demonstration that parathyroid hormone and parathyroid hormone-related protein stimulate expression by osteoblasts of interleukin-6 and leukemia inhibitory factor. J Bone Miner Res. 11:1996;754-759.
53. Pottratz S.T., Bellido T., Mocharla H., Crabb D., Manolagas S.C. 17β-Estradiol inhibits expression of human promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest. 93:1994;944-950.
54. Ray A., Prefontaine K.E., Ray P. Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem. 269:1994;12940-12946.
55. Rickard D., Russel G., Gowen M. Oestradiol inhibits the release of tumor necrosis factor but not interleukin 6 from adult human osteoblasts in vitro. Osteopor Int. 2:1992;94-102.
56. Rifas, L., Kenney, J. S., Marcelli, M., Pacifici, R., Cheng, S.-L., Sawson, L. L., and Avioli, L. V. Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: Evidence that induction by interleukin-1 and tumor necrosis factor-α is not regulated by ovarian steroids. Endocrinology 136:4056-4067; 1995.
57. Riggs B.L., Jowsey J., Goldsmith R.S., Kelly P.J., Hoffman D.L., Arnaud C.D. Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis. J Clin Invest. 51:1972;1659-1663.
58. Rogers A., Eastell R. Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood. J Bone Miner Res. 13:1998;1577-1586.
59. Sakagami Y., Girasole G., Yu X.P., Boswell H.S., Manolagas S.C. Stimulation of interleukin-6 production by either calcitonin gene-related peptide or parathyroid hormone in two phenotypically distinct bone marrow-derived murine stromal cell lines. J Bone Miner Res. 8:1993;811-816.
60. Sarma U., Edwards M., Motoyoshi K., Flanagan A.M. Inhibition of bone resorption by 17beta-estradiol in human bone marrow cultures. J Cell Physiol. 175:1998;99-108.
61. Stein B., Yang M.X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ Mol Cell Biol. 15:1995;4971-4979.
62. Sun W., Keller E., Stebler B., Ershler W. Estrogen inhibits phorbol ester-induce IκBα transcription and protein degradation. Biochem Biophys Res Comm. 244:1998;691-695.
63. Tabibzadeh S., Kong Q.F., Babaknia A., May L.T. Progressive rise in the expression of interleukin-6 in human endometrium during menstrual cycle is initiated during the implantation window. Mol Hum Reprod. 1:1995;2793-2799.
64. Tamura T., Udagawa N., Takahashi N., Miyaura C., Tanaka S., Koishihara Y., Ohsugi Y., Kumaki K., Taga T., Kishimoto T., Suda T. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin-6. Proc Natl Acad Sci USA. 90:1993;11924-11928.
65. U.S. Department of Agriculture. Data Tables: Results from USDA's 1996 Continuing Survey of Food Intakes by Individuals and 1996 Diet and Health Knowledge Survey. Washington, DC: ARS Food Surveys Research Group.
66. Vargas S.J., Kawaguchi H., Kalinowski J., Naprta A., Pilbeam C., Raisz L., Lorenzo J.A. Ovariectomy or estrogen treatment do not alter interleukin-6 mRNA expression in adult murine bone and bone marrow. J Bone Marrow Res. 9:1995;S388. [abstract].
67. Vargas S.J., Naprta A., Lee S.K., Kalinowski J., Kawaguchi H., Pilbeam C.C., Raisz L.G., Lorenzo J.A. Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy. J Bone Miner Res. 11:1996;1926-1934.
68. Zheng S.X., Vrindts Y., Lopez M., De Groote D., Zangerle P.F., Collette J., Franchimont N., Geenen V., Albert A., Reginster J.Y. Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas. 26:1997;63-71.